MIT Creates 3D Scaffold for Growing Stem Cells
News Jan 08, 2007
Stem cells grew, multiplied and differentiated into brain cells on a three-dimensional scaffold of tiny protein fragments designed to be more like a living body than any other cell culture system.
An MIT engineer and Italian colleagues report the invention- which may one day replace the ubiquitous Petri dish for growing cells- in the Dec. 27 issue of the Public Library of Science (PLoS) ONE.
Shuguang Zhang, associate director of MIT's Center for Biomedical Engineering, is a pioneer in coaxing tiny fragments of amino acids called self-assembling peptides to organize themselves into useful structures.
Working with visiting graduate student Fabrizio Gelain from Milan, Zhang created a designer scaffold from a network of protein nanofibers, each 5,000 times thinner than a human hair and containing pores up to 20,000 times smaller than the eye of a needle.
The researchers were able to grow a healthy colony of adult mouse stem cells on the three-dimensional scaffold without the drawbacks of two-dimensional systems.
In addition to helping researchers get a picture of how cells grow and behave in the body, the synthetic structure can provide a conducive microenvironment for tissue cell cultures and tissues used in regenerative medicine, such as skin grafts or neurons to replace brain cells lost to injury or disease.
The scaffold itself can be transplanted directly into the body with no ill effects.
"The time has come to move on from two-dimensional dishes to culture systems that better represent the natural context of cells in tissues and organs," said Zhang, whose coauthors on the paper, in addition to Gelain, are from institutes and medical schools in Milan, Italy.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.